These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 20403794)

  • 1. Manganese and Parkinson's disease: a critical review and new findings.
    Guilarte TR
    Environ Health Perspect; 2010 Aug; 118(8):1071-80. PubMed ID: 20403794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manganese and Parkinson's disease: a critical review and new findings.
    Guilarte TR
    Cien Saude Colet; 2011 Nov; 16(11):4549-66. PubMed ID: 22124833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine transporter density is decreased in parkinsonian patients with a history of manganese exposure: what does it mean?
    Kim Y; Kim JM; Kim JW; Yoo CI; Lee CR; Lee JH; Kim HK; Yang SO; Chung HK; Lee DS; Jeon B
    Mov Disord; 2002 May; 17(3):568-75. PubMed ID: 12112209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manganese-Induced Parkinsonism Is Not Idiopathic Parkinson's Disease: Environmental and Genetic Evidence.
    Guilarte TR; Gonzales KK
    Toxicol Sci; 2015 Aug; 146(2):204-12. PubMed ID: 26220508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology of manganese-associated neurotoxicity.
    Racette BA; Aschner M; Guilarte TR; Dydak U; Criswell SR; Zheng W
    Neurotoxicology; 2012 Aug; 33(4):881-6. PubMed ID: 22202748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Manganese neurotoxicity: lessons learned from longitudinal studies in nonhuman primates.
    Burton NC; Guilarte TR
    Environ Health Perspect; 2009 Mar; 117(3):325-32. PubMed ID: 19337503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Manganese and its role in Parkinson's disease: from transport to neuropathology.
    Aschner M; Erikson KM; Herrero Hernández E; Tjalkens R
    Neuromolecular Med; 2009; 11(4):252-66. PubMed ID: 19657747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manganese-Induced Parkinsonism and Parkinson's Disease: Shared and Distinguishable Features.
    Kwakye GF; Paoliello MM; Mukhopadhyay S; Bowman AB; Aschner M
    Int J Environ Res Public Health; 2015 Jul; 12(7):7519-40. PubMed ID: 26154659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From manganism to manganese-induced parkinsonism: a conceptual model based on the evolution of exposure.
    Lucchini RG; Martin CJ; Doney BC
    Neuromolecular Med; 2009; 11(4):311-21. PubMed ID: 20012385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are there common biochemical and molecular mechanisms controlling manganism and parkisonism.
    Roth JA
    Neuromolecular Med; 2009; 11(4):281-96. PubMed ID: 19757210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Manganese neurotoxicity: new perspectives from behavioral, neuroimaging, and neuropathological studies in humans and non-human primates.
    Guilarte TR
    Front Aging Neurosci; 2013; 5():23. PubMed ID: 23805100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neuropathology of manganese-induced Parkinsonism.
    Perl DP; Olanow CW
    J Neuropathol Exp Neurol; 2007 Aug; 66(8):675-82. PubMed ID: 17882011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for cortical dysfunction and widespread manganese accumulation in the nonhuman primate brain following chronic manganese exposure: a 1H-MRS and MRI study.
    Guilarte TR; McGlothan JL; Degaonkar M; Chen MK; Barker PB; Syversen T; Schneider JS
    Toxicol Sci; 2006 Dec; 94(2):351-8. PubMed ID: 16968886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Considerations on manganese (Mn) treatments for in vitro studies.
    Bowman AB; Aschner M
    Neurotoxicology; 2014 Mar; 41():141-2. PubMed ID: 24509086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial dysfunction and loss of Parkinson's disease-linked proteins contribute to neurotoxicity of manganese-containing welding fumes.
    Sriram K; Lin GX; Jefferson AM; Roberts JR; Wirth O; Hayashi Y; Krajnak KM; Soukup JM; Ghio AJ; Reynolds SH; Castranova V; Munson AE; Antonini JM
    FASEB J; 2010 Dec; 24(12):4989-5002. PubMed ID: 20798247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manganese intoxication in the rhesus monkey: a clinical, imaging, pathologic, and biochemical study.
    Olanow CW; Good PF; Shinotoh H; Hewitt KA; Vingerhoets F; Snow BJ; Beal MF; Calne DB; Perl DP
    Neurology; 1996 Feb; 46(2):492-8. PubMed ID: 8614520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Essential points to differentiate various diseases causing parkinsonism].
    Kuzuhara S
    Nihon Rinsho; 2000 Oct; 58(10):2049-53. PubMed ID: 11068445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanism of manganese exposure-induced dopaminergic toxicity.
    Prabhakaran K; Ghosh D; Chapman GD; Gunasekar PG
    Brain Res Bull; 2008 Jul; 76(4):361-7. PubMed ID: 18502311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative damage and neurodegeneration in manganese-induced neurotoxicity.
    Milatovic D; Zaja-Milatovic S; Gupta RC; Yu Y; Aschner M
    Toxicol Appl Pharmacol; 2009 Oct; 240(2):219-25. PubMed ID: 19607852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Manganese-induced neurotoxicity: a review of its behavioral consequences and neuroprotective strategies".
    Peres TV; Schettinger MR; Chen P; Carvalho F; Avila DS; Bowman AB; Aschner M
    BMC Pharmacol Toxicol; 2016 Nov; 17(1):57. PubMed ID: 27814772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.